Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 149-155

  Yokoigawa, Norio ^a   Takeuchi, Noriko ^b   Toda, Munetoyo ^c   Inoue, Mizue ^c   Kaibori, Masaki ^a   Yanagida, Hidesuke ^a   Inaba, Takaaki ^b   Tanaka, Hironori ^a   Ogura, Tokuhiro ^a   Takada, Hideho ^a   Okumura, Tadayoshi ^a   Kwon, A Hon ^a   Kamiyama, Yasuo ^a   Nakada, Hiroshi ^b,c  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KYOTO SANGYO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Gastrointestinal cancer; Monocytes; Mucin; PGE2; Scavenger receptor

Indexed keywords

MUCIN; PLASMA PROTEIN; PROSTAGLANDIN E2; SCAVENGER RECEPTOR; SEPHAROSE;

ARTICLE; COLON CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; STOMACH CANCER;

AMINO ACID SEQUENCE; BLOOD PROTEINS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETODOLAC; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOMETHACIN; MOLECULAR SEQUENCE DATA; MONOCYTES; MUCINS; OLIGOPEPTIDES; RECEPTORS, SCAVENGER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFOGLYCOSPHINGOLIPIDS;

EID: 33845646735     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.01.004     Document Type: Article

References (24)

1. Tabata T., Hazama S., Yoshino S., and Oka M. Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers. Am. J. Surg. 177 (1999) 203-208
2. Eberhart C.E., and DuBois R.N. Eicosanoids and the gastrointestinal tract. Gastroenterolgy 109 (1995) 285-301
3. Smith W.L., and DeWitt D.L. Biochemistry of prostaglandin endoperoxidase H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin. Nephrol. 15 (1995) 179-194
4. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthase (cyclooxygenase)-1 and -2. J. Biol. Chem. 271 (1996) 33157-33160
5. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., and Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55 (1995) 2556-2559
6. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55 (1995) 3785-3789
7. Williams C.S., Luongo C., Radhika A., Chang T., Lamps L.W., Nanney L.B., et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111 (1996) 1134-1140
8. Kawamori T., Rao C.V., Seibet K., and Reddy B.S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58 (1998) 409-412
9. Gupta R.A., and DuBois R.N. Aspirin, NSAIDs, and colon cancer prevention: mechanisms?. Gastroenterology 114 (1998) 1095-1098
10. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc (Delta 716) knockout mice. Nat. Med. 7 (2001) 1048-1051
11. Oshima H., Oshima M., Inaba K., and Taketo M.M. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. Eur. Mol. Biol. Org. J. 23 (2004) 1669-1678
12. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., et al. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87 (1996) 803-809
13. Kim Y.S., Gum Jr. J., and Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj. J. 13 (1996) 693-707
14. Miyake M., Taki T., Hitomi S., and Hakomori S. Correlation of expression of H/Le(y)/Le(b) antigens survival in patients with carcinoma of the lung. N. Engl J. Med. 327 (1992) 14-18
15. Inaba T., Sano H., Kawahito Y., Kawahito Y., Hla T., Akita K., et al. Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc. Natl Acad. Sci. USA 100 (2003) 2736-2741
16. Kitagawa H., Nakada H., Numata Y., Kurosaka A., Fukui S., Funakoshi I., et al. Immunoaffinity isolation of a sialyl Le(a) oligosaccharide from human milk. J. Biochem. 104 (1988) 591-594
17. Doi T., Higashino K., Kurihara Y., Miyazaki T., Nakamura H., Uesugi S., et al. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptor. J. Biol. Chem. 268 (1993) 2126-2133
18. Schneider C., Newman R.A., Sutherland D.R., Asser U., and Greaves M.F. A one-step purification using a high efficiency immunomatrix. J. Biol. Chem. 25 (1982) 10766-10769
19. Steinbach G., Lynch P.M., Phillips R.K., Wallace M.H., Hawk E., Gordon G.B., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl J. Med. 342 (2000) 1942-1956
20. North G.L. Celecoxib as adjunctive therapy for treatment of colorectal cancer. Ann. Pharmacother. 35 (2001) 1638-1643
21. Kodama T., Reddy P., Kishimoto C., and Krieger M. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 85 (1988) 9238-9242
22. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., and Krieger M. Type I macrophage scavenger receptor contain alpha-helical and collagen-like coiled coils. Nature 343 (1990) 531-535
23. Hampton R.Y., Golenbock D.T., Penman M., Krieger M., and Raetz C.R. Recognition and plasma clearance of endotoxin by scavenger receptor. Nature 352 (1991) 342-344
24. Mazumder A., Neamati N., Sunder S., Shulz J., Pertz H., Eich E., and Pommier Y. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J. Med. Chem. 40 (1997) 3057-3063